Lantern Pharma Inc.

NASDAQ: LTRN · Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT

Lantern Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-19.25M -19.88M -20.78M -19.09M -17.75M -17.53M -15.96M -15.16M -14.26M -14.01M -14.26M -14.42M -16.21M -14.03M -12.36M -11.72M -9.37M -7.88M
Depreciation & Amortization
64.69K 106.45K 147.02K 140.12K 139.44K 96.68K 54.96K 13.4K 12.64K 11.51K 10.08K 9.31K 8.21K 7.41K 6.76K 5.86K 5.11K 4.2K
Stock-Based Compensation
773.04K 746.59K 732.89K 598.23K 609.82K 868.04K 1.07M 1.25M 1.36M 1.25M 1.19M 1.1M 1.03M 983.03K 961.54K 1.74M 1.56M 1.42M
Other Working Capital
779.06K -183.76K 591.72K 475.59K 344.24K 1.81M 1.01M 935.59K 710.14K -951.7K -1.5M -2.32M -2.4M -1.33M -950.47K -510.92K -188.76K -103.93K
Other Non-Cash Items
75.98K -262.56K -140.06K -847.69K -462.31K -312.14K -360.38K 92.92K 351.16K 347.06K 369.2K 646.14K 360.65K 239.37K 287.35K 11.06K -936.06 84.29K
Deferred Income Tax
n/a n/a n/a 180.44K 275.94K 314.87K 314.87K 134.43K 38.93K 312.05K 537.29K 744.16K 759.07K 447.03K 221.79K 14.91K n/a n/a
Change in Working Capital
468.06K 166.42K 2.23M 1.79M 1.93M 2.91M 538.02K 39.14K -1.56M -1.12M -611.86K -14.86K 1.49M 802.62K 599.96K -75.43K -440.97K -633.3K
Operating Cash Flow
-17.87M -19.12M -17.81M -17.23M -15.26M -13.66M -14.35M -13.63M -14.06M -13.2M -12.77M -12.14M -12.78M -11.77M -10.59M -10.12M -8.33M -7.09M
Capital Expenditures
-7.27K -11.54K -12.6K -14.59K -16.34K -12.07K -18.73K -20.61K -22.54K -36.72K -27.84K -20.89K -17.66K -15.5K -15.5K -20.49K -20.33K -8.32K
Cash Acquisitions
n/a n/a n/a -261 -497 -497 -2.15M -2.15M -2.15M -131.02K 2.02M 2.02M 2.02M n/a n/a n/a n/a n/a
Purchase of Investments
-11.36M -16.25M -17.28M -19.03M -16.65M -11.11M -8.2M -7.23M -7.82M -7.01M -3.91M -3.62M -3.3M -19.58M -19.58M -19.28M -18.28M n/a
Sales Maturities Of Investments
4.92M -2.21M 3.25M 1.82M 16.39M 10.59M 7.28M 6.67M 6.95M 6.09M 4.12M 2.98M 1.73M 240.61K 64.09K n/a n/a n/a
Other Investing Acitivies
17.41M 25.63M 17.41M 17.41M 497.77 40.53 2.15M 2.15M 2.15M 131.02K -2.02M -1.95M -1.96M 42.5K 42.33K -16.16M -16.15M -16.13M
Investing Cash Flow
10.96M 7.16M 3.37M 178.29K -270.32K -525.5K -930.21K -583.53K -889.62K -958.13K 179.27K -657.55K -1.59M -19.35M -19.53M -19.3M -18.3M -8.32K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -102.83K 55.23K
Common Stock Repurchased
n/a n/a n/a -500K -500K -500K -500K n/a n/a n/a -2.48M -3.42M -3.42M -3.42M -939.67K -0.00 -0.00 n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a -2.48M -2.48M -2.48M -2.18M -573.02K -573.02K -573.02K -74.58M -73.71M -73.71M -76.46M
Financial Cash Flow
11.99K 11.99K 66.71K -433.29K -445.28K -1.14M -1.19M -690.8K -690.8K n/a -2.18K -874.99K -874.99K -874.99K 63.42M 64.29M 64.19M 87.85M
Net Cash Flow
-6.92M -11.98M -14.43M -17.47M -15.99M -14.66M -15.81M -14.23M -14.94M -14.17M -14.78M -15.87M -17.45M -34.18M 33.3M 34.87M 37.56M 80.74M
Free Cash Flow
-17.87M -19.13M -17.83M -17.24M -15.27M -13.67M -14.37M -13.65M -14.08M -13.23M -12.8M -12.16M -12.8M -11.79M -10.61M -10.14M -8.35M -7.1M